Table 2 21 Colocalized loci identified by colocalization analysis performed on 51 pleiotropic loci (PP.H4 > 0.7)

BMI & EnOC

rs7204632

16p11.2

16:30591675–30,660,700

0.864

BMI & EC

rs11066188

12q24.13

12:111826477–112,906,415

0.707

BMI & EC

rs11865403

16p12.3

16:19706199–19,831,532

0.789

BMI & EC

rs3922668

16p11.2

16:28510393–29,008,079

0.766

BMI & EC

rs12602912

17q24.2

17:65822573–66,096,529

0.987

BMI & PCOS

rs2990997

1q31.1

1:190112653–190,163,532

0.842

BMI & PCOS

rs9819875

3p22.1

3:42303074–42,334,191

0.911

BMI & PCOS

rs12981256

19p13.3

19:1812682–1,920,342

0.988

BMI & GH

rs1013293

1p31.3

1:62488918–62,634,303

0.981

BMI & GH

rs4988235

2q21.3

2:135771974–136,823,866

0.828

BMI & GH

rs6985109

8p23.1

8:9735970–11,450,422

0.863

BMI & GH

rs11066188

12q24.13

12:111826477–112,906,415

0.925

BMI & PE

rs656980

11q13.1

11:65575263–65,663,547

0.943

BMI & PE

rs9955276

18p11.32

18:1811604–1,914,051

0.975

BMI & GDM

rs17024258

1p13.3

1:110078255–110,216,436

0.999

BMI & GDM

rs12713419

2p23.3

2:25074874–25,453,968

0.865

BMI & GDM

rs4684847

3p25.2

3:12329783–12,413,339

0.988

BMI & GDM

rs7717348

5q15

5:95388015–95,765,413

0.998

BMI & GDM

rs1579557

6p21.2

6:40348653–40,383,533

0.758

BMI & GDM

rs11663558

18q11.2

18:21075441–21,165,409

0.980

BMI & GDM

rs11671664

19q13.32

19:46148237–46,177,235

0.983